Bontilao, Estrella T.
HRN: 24-78-00 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/20/2024
CEFAZOLIN 1GM (VIAL)
04/20/2024
04/27/2024
IV
500mg
Q6hrs
For ORIF
Waiting Final Action
Indication: Prophylaxis Type of Infection: Bone & JointSkin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes